That is wonderful!! I know it is not the small molecule uses that the majority of stockholders are focused on, but down the line I believe these industrial use royalties could be astronomical as the uses are so widespread. If IPIX ever does sell the entire B platform, I think it will only be for the medical (small molecule) side and not the industrial side.

Keeps getting better and better.